Cyclooxygenase-2 Inhibitors in Aspirin-Sensitive Asthma
作者： Michael Passero , Sapna Chowdhry
关键词:
摘要:
sci-hub.se 参考文章(5)
A Szczeklik, The cyclooxygenase theory of aspirin-induced asthma European Respiratory Journal. ,vol. 3, pp. 588- 593 ,(1990)
Donald D. Stevenson, Ronald A. Simon, Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. The Journal of Allergy and Clinical Immunology. ,vol. 108, pp. 47- 51 ,(2001) , 10.1067/MAI.2001.116290
Cristina Martín-García, Miguel Hinojosa, Pilar Berges, Encarnación Camacho, Rosa García-Rodriguez, Teresa Alfaya, Alberto Iscar, Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest. ,vol. 121, pp. 1812- 1817 ,(2002) , 10.1378/CHEST.121.6.1812
A. Szczeklik, E. Nizankowska, G. Bochenek, K. Nagraba, F. Mejza, M. Swierczynska, Safety of a specific COX‐2 inhibitor in aspirin‐induced asthma Clinical & Experimental Allergy. ,vol. 31, pp. 219- 225 ,(2001) , 10.1046/J.1365-2222.2001.01075.X
Barbro Dahlén, Andrew Szczeklik, John J. Murray, Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. The New England Journal of Medicine. ,vol. 344, pp. 142- 142 ,(2001) , 10.1056/NEJM200101113440215